Table 1 Clinical characteristics of enrolled patients who underwent dilatation treatment.
From: A comparison of three kinds of balloon dilatations for patients with benign esophageal strictures
Group S | Group D | Group L | P-value | |
|---|---|---|---|---|
Total no. of patients | 25 | 22 | 35 | – |
Gender, Male | 20 (80.0) | 14 (63.6) | 24 (68.6) | 0.4380 |
Mean age (years) | 64.1 ± 12.2 | 59.4 ± 16.6 | 66.3 ± 9.6 | 0.1390 |
Course of disease (months) | 3.0 (1.5, 10.5) | 3.0 (2.0, 6.0) | 3.0 (1.0, 6.0) | 0.4001 |
Preoperative treatments | ||||
Chemotherapy/radiotherapy or chemoradiotherapy | 9 (36.0) | 8 (36.4) | 8 (22.9) | 0.4320 |
Immune or targeted treatment | 3 (12.0) | 2 (9.1) | 6 (17.1) | 0.8160 |
Radical resection of esophageal cancer | 17 (68.0) | 10 (45.5) | 25 (71.4) | 0.1192 |
Other surgical treatments | 6 (24.0) | 7 (31.8) | 9 (25.7) | 0.8175 |
Cause of stricture | ||||
Postoperative stenosis | 17 (68.0) | 10 (45.5) | 25 (71.4) | |
Endoscopic submucosal dissection | 2 (8.0) | 1 (4.5) | 6 (17.1) | 0.0659 |
Radiation induced stricture | 2 (8.0) | 4 (18.2) | 1 (2.9) | |
Others | 4 (16.0) | 7 (31.8) | 3 (8.6) | |
Severe/moderate/mild stricture | 16 (64.0)/7 (28.0)/2 (8.0) | 13 (59.1)/8 (36.4)/1 (4.5) | 18 (51.4)/12 (34.3)/5 (14.3) | 0.7121 |
Interval from surgery to dysphagia | 3.3 (2.3, 5.8) | 4.0 (2.3, 7.2) | 3.0 (2.0, 5.0) | 0.1185 |
Upper/middle/lower esophagus | 19 (76.0)/4 (16.0)/2 (8.0) | 14 (63.6)/5 (22.7)/3 (13.6) | 32 (91.4)/1 (2.9)/2 (5.7) | 0.1271 |
Comorbidities | ||||
Old cerebral infarction | 2 (8.0) | 1 (4.5) | 1 (2.9) | 0.6576 |
Coronary disease | 3 (12.0) | 2 (9.1) | 2 (5.7) | 0.6874 |
Hypertension | 5 (20.0) | 1 (4.5) | 7 (20.0) | 0.2367 |
Diabetes mellitus | 3 (12.0) | 3 (13.6) | 4 (11.4) | 0. 9691 |
